A randomized phase III trial of oral S-1 plus cisplatin versus docetaxel plus cisplatin in Japanese patients with advanced non-small-cell lung cancer: TCOG0701 CATS trialKaoru Kubota, Satoshi Kudoh, Hiroshi Sakai et al.|Annals of Oncology|2015Cited by 89
Heterogeneity of EGFR mutations in a patient treated with gefitinib as neo-adjuvant chemotherapyKosuke Mizoguchi, Shigeru Kohno, Kohei Motoshima et al.|Cancer Treatment Communications|2015Cited by 0